SCHEMBL1974137

SCHEMBL1974137

CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.80
HSPD1 P10809 1/20 0.80
HSPE1 P61604 1/20 0.80
TST Q16762 1/20 0.80
RECQL P46063 1/20 0.80
BLM P54132 1/20 0.80
TDP1 Q9NUW8 1/20 0.80
PPM1A P35813 2/20 0.48
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ENPP2 Q13822 4/20 0.45
LPAR6 P43657 1/20 0.45
LPAR1 Q92633 1/20 0.45
LPAR4 Q99677 1/20 0.45
LPAR5 Q9H1C0 1/20 0.45
LPAR2 Q9HBW0 1/20 0.45
LPAR3 Q9UBY5 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22099880 1.00 MAPT (0.80) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL7805056 1.00 MAPT (0.80) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL29804572 1.00 MAPT (0.80) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL6429749 1.00 MAPT (0.80) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL17068354 0.93 MAPT (0.77) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL1869725 0.91 MAPT (0.66) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL16950247 0.91 MAPT (0.73) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL9722188 0.91 HSPD1 (0.67) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL17541984 0.90 MAPT (0.65) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL17542097 0.90 MAPT (0.65) MAPTHSPD1HSPE1TSTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210015777-A1 HEALING TOPICAL COMPOSITION FLORENGALE, LLC 2021-01-21 US claimed
US-10682324-B2 Healing topical composition FLORENGALE, LLC (US) 2020-06-16 US claimed
EP-2335500-B1 FERMENTATION PRODUCT CONTAINING EQUOL-PRODUCING MICROORGANISM HAVING MAINTAINED EQUOL-PRODUCING ABILITY, AND METHOD FOR PRODUCING SAME OTSUKA PHARMA CO LTD (JP) 2019-09-18 EP claimed
US-20180071205-A1 Stable Vitamin C System DISALVO JEANE (US) 2018-03-15 US claimed
US-20160158134-A1 Stable Vitamin C System DISALVO JEANE (US) 2016-06-09 US claimed
US-4870047-A RESISTANCE TO FADING OR ERASURE APPLETON PAPERS INC. (US) 1989-09-26 US claimed
US-20240164399-A1 CONTAINER-PACKED TEA BEVERAGE WITH REDUCED LIQUID COLOR DEGRADATION DURING HEAT STERILIZATION, AND METHOD FOR MANUFACTURING SAME KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2024-05-23 US disclosed
US-20240156122-A1 PACKAGED TEA BEVERAGE IN WHICH PAPER ODOR IS SUPPRESSED, AND PRODUCTION METHOD FOR SAME KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2024-05-16 US disclosed
EP-4309508-A1 PACKAGED TEA BEVERAGE IN WHICH PAPER ODOR IS SUPPRESSED, AND PRODUCTION METHOD FOR SAME KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2024-01-24 EP disclosed
EP-4309507-A1 CONTAINER-PACKED TEA BEVERAGE WITH REDUCED LIQUID COLOR DEGRADATION DURING HEAT STERILIZATION, AND METHOD FOR MANUFACTURING SAME KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2024-01-24 EP disclosed
CN-117295404-A Packaged tea beverage with suppressed deterioration of color of liquid during heat sterilization, and its preparation method 麒麟控股株式会社 2023-12-26 CN disclosed
CN-117279514-A Packaged tea beverage with suppressed paper smell and its preparation method 麒麟控股株式会社 2023-12-22 CN disclosed
CN-116583560-A Rubber composition for hot air crosslinking, crosslinked rubber, and method for producing crosslinked rubber 日油株式会社 2023-08-11 CN disclosed
US-5780198-A MULTILAYER; CONTAINS A HYDRAZINE NUCLEATING AGENT AND A REDOX COMPOUND CAPABLE OF RELEASING A DEVELOPMENT INHIBITOR WHEN THE REDOX COMPOUND IS OXIDIZED; ULTRAHIGH CONTRAST IMAGE WITH BROAD DOT GRADATION FUJI PHOTO FILM CO., LTD. (JP) 1998-07-14 US disclosed
EP-0848955-A1 Anti-stress agent for animals comprising an ascorbic acid derivative SHOWA DENKO KABUSHIKI KAISHA (JP) 1998-06-24 EP disclosed
EP-0420005-B1 High contrast silver halide photographic material FUJI PHOTO FILM CO LTD (JP) 1996-07-10 EP disclosed
EP-0420005-A1 high contrast silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1991-04-03 EP disclosed
US-4870047-A RESISTANCE TO FADING OR ERASURE APPLETON PAPERS INC. (US) 1989-09-26 US disclosed
US-4791096-A Color-forming composition TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-12-13 US disclosed
EP-0269443-A2 Color-forming composition Takeda Chemical Industries, Ltd. (JP) 1988-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210015777-A1 HEALING TOPICAL COMPOSITION CUTA, CSDE1, SRI MAPT 605/4885HSPD1 1004/4885HSPE1 152/4885
US-10682324-B2 Healing topical composition CUTA, CSDE1, SRI MAPT 605/4885HSPD1 1004/4885HSPE1 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.